These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 16974128)

  • 1. Quantitative analysis of chondroitin sulfate in tear fluids following laser in situ keratomileusis.
    Nishio M; Arai K
    Ophthalmic Res; 2006; 38(5):274-9. PubMed ID: 16974128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nerve growth factor concentration and implications in photorefractive keratectomy vs laser in situ keratomileusis.
    Lee HK; Lee KS; Kim HC; Lee SH; Kim EK
    Am J Ophthalmol; 2005 Jun; 139(6):965-71. PubMed ID: 15953424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activator inhibitor in human tears after laser refractive surgery.
    Csutak A; Silver DM; Tozsér J; Steiber Z; Bagossi P; Hassan Z; Berta A
    J Cataract Refract Surg; 2008 Jun; 34(6):897-901. PubMed ID: 18498992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratan sulfate and chondroitin/dermatan sulfate in maximally recovered hypocellular stromal interface scars of postmortem human LASIK corneas.
    Zhang Y; Schmack I; Dawson DG; Grossniklaus HE; Conrad AH; Kariya Y; Suzuki K; Edelhauser HF; Conrad GW
    Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2390-6. PubMed ID: 16723448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of corneal sensitivity and tear function following Epi-LASIK or laser in situ keratomileusis for myopia.
    Kalyvianaki MI; Katsanevaki VJ; Kavroulaki DS; Kounis GA; Detorakis ET; Pallikaris IG
    Am J Ophthalmol; 2006 Oct; 142(4):669-71. PubMed ID: 17011861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tear secretion following excimer laser in situ keratomileusis.
    Siganos DS; Popescu CN; Siganos CS; Pistola G
    J Refract Surg; 2002; 18(2):124-6. PubMed ID: 11934198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of laser in situ keratomileusis on tear stability.
    Yu EY; Leung A; Rao S; Lam DS
    Ophthalmology; 2000 Dec; 107(12):2131-5. PubMed ID: 11097583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corneal barrier function, tear film stability, and corneal sensation after photorefractive keratectomy and laser in situ keratomileusis.
    Nejima R; Miyata K; Tanabe T; Okamoto F; Hiraoka T; Kiuchi T; Oshika T
    Am J Ophthalmol; 2005 Jan; 139(1):64-71. PubMed ID: 15652829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A control-matched comparison of laser epithelial keratomileusis and laser in situ keratomileusis for low to moderate myopia.
    Tobaigy FM; Ghanem RC; Sayegh RR; Hallak JA; Azar DT
    Am J Ophthalmol; 2006 Dec; 142(6):901-8. PubMed ID: 17157575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic changes of tear fluid matrix metralloproteinase-9 within 1 year after laser in situ keratomileusis.
    Ji H; Chen A; Zhang W; Gu H; Zhang Z; Fu J
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jul; 34(8):1079-82. PubMed ID: 25176071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual outcomes of wavefront-guided laser in situ keratomileusis in eyes with moderate or high myopia and compound myopic astigmatism.
    Bababeygy SR; Zoumalan CI; Manche EE
    J Cataract Refract Surg; 2008 Jan; 34(1):21-7. PubMed ID: 18165076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between the matrix metalloproteinase-9 activity and chondroitin sulfate concentrations in tear fluid after laser in situ keratomileusis.
    Mutoh T; Nishio M; Matsumoto Y; Arai K
    Clin Ophthalmol; 2010 Jul; 4():823-8. PubMed ID: 20689736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-year clinical results after epi-LASIK for myopia.
    Katsanevaki VJ; Kalyvianaki MI; Kavroulaki DS; Pallikaris IG
    Ophthalmology; 2007 Jun; 114(6):1111-7. PubMed ID: 17320960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of dry-eye disease severity after laser in situ keratomileusis and laser-assisted subepithelial keratectomy.
    Dooley I; D'Arcy F; O'Keefe M
    J Cataract Refract Surg; 2012 Jun; 38(6):1058-64. PubMed ID: 22624906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine and chemokine levels in tears and in corneal fibroblast cultures before and after excimer laser treatment.
    Leonardi A; Tavolato M; Curnow SJ; Fregona IA; Violato D; Alió JL
    J Cataract Refract Surg; 2009 Feb; 35(2):240-7. PubMed ID: 19185237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A predictive model for postoperative intraocular pressure among patients undergoing laser in situ keratomileusis (LASIK).
    Yang CC; Wang IJ; Chang YC; Lin LL; Chen TH
    Am J Ophthalmol; 2006 Mar; 141(3):530-536. PubMed ID: 16490501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topographic and biomechanical differences between hyperopic and myopic laser in situ keratomileusis.
    Qazi MA; Roberts CJ; Mahmoud AM; Pepose JS
    J Cataract Refract Surg; 2005 Jan; 31(1):48-60. PubMed ID: 15721696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of preoperative tear function on early functional visual acuity after laser in situ keratomileusis.
    Tanaka M; Takano Y; Dogru M; Toda I; Asano-Kato N; Komai-Hori Y; Tsubota K
    J Cataract Refract Surg; 2004 Nov; 30(11):2311-5. PubMed ID: 15519080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of visual results between laser-assisted subepithelial keratectomy and epipolis laser in situ keratomileusis to correct myopia and myopic astigmatism.
    Teus MA; de Benito-Llopis L; García-González M
    Am J Ophthalmol; 2008 Sep; 146(3):357-362. PubMed ID: 18614136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One year follow-up of contrast sensitivity following conventional laser in situ keratomileusis and laser epithelial keratomileusis.
    Townley D; Kirwan C; O'Keefe M
    Acta Ophthalmol; 2012 Feb; 90(1):81-5. PubMed ID: 20070279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.